CASR Gene Hyperparathyroidism Neonatal Severe Genetic Test
Components
- Test Name: CASR Gene Hyperparathyroidism Neonatal Severe Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test type: Hepatology Nephrology Endocrinology Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for CASR Gene Hyperparathyroidism, neonatal severe NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CASR Gene Hyperparathyroidism, neonatal severe NGS Genetic DNA Test gene CASR.
Test Details
CASR gene hyperparathyroidism, neonatal severe is a genetic disorder that affects the function of the parathyroid glands. The CASR gene provides instructions for making a protein called the calcium-sensing receptor, which is involved in regulating the levels of calcium in the body.
Individuals with CASR gene hyperparathyroidism, neonatal severe have mutations in the CASR gene that impair the function of the calcium-sensing receptor. This leads to abnormally high levels of calcium in the blood, a condition known as hypercalcemia.
The excessive calcium levels can cause a variety of symptoms, including poor feeding, vomiting, dehydration, constipation, failure to thrive, and kidney problems.
NGS (Next Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of CASR gene hyperparathyroidism, neonatal severe, NGS genetic testing can be used to identify mutations in the CASR gene that are responsible for the condition.
This testing can help confirm a diagnosis and guide appropriate treatment and management options. It is important to note that genetic testing for CASR gene hyperparathyroidism, neonatal severe is typically recommended for individuals with symptoms suggestive of the condition, a family history of the disorder, or for prenatal testing in families with a known CASR gene mutation.
Genetic counseling is also often recommended before and after genetic testing to discuss the implications and potential outcomes of the test results.
Test Name | CASR Gene Hyperparathyroidism neonatal severe Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Hepatology Nephrology Endocrinology Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CASR Gene Hyperparathyroidism, neonatal severe NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CASR Gene Hyperparathyroidism, neonatal severe NGS Genetic DNA Test gene CASR |
Test Details |
CASR gene hyperparathyroidism, neonatal severe is a genetic disorder that affects the function of the parathyroid glands. The CASR gene provides instructions for making a protein called the calcium-sensing receptor, which is involved in regulating the levels of calcium in the body. Individuals with CASR gene hyperparathyroidism, neonatal severe have mutations in the CASR gene that impair the function of the calcium-sensing receptor. This leads to abnormally high levels of calcium in the blood, a condition known as hypercalcemia. The excessive calcium levels can cause a variety of symptoms, including poor feeding, vomiting, dehydration, constipation, failure to thrive, and kidney problems. NGS (Next Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of CASR gene hyperparathyroidism, neonatal severe, NGS genetic testing can be used to identify mutations in the CASR gene that are responsible for the condition. This testing can help confirm a diagnosis and guide appropriate treatment and management options. It is important to note that genetic testing for CASR gene hyperparathyroidism, neonatal severe is typically recommended for individuals with symptoms suggestive of the condition, a family history of the disorder, or for prenatal testing in families with a known CASR gene mutation. Genetic counseling is also often recommended before and after genetic testing to discuss the implications and potential outcomes of the test results. |